CASEY ORZECHOWICZ: Open Payments
NPI 1073074597 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,935 in 135 payments from 24 companies in 2025. Trend: 2023 $2,724 · 2024 $6,488 · 2025 $4,935
Food & beverage: $3,333Travel & lodging: $1,602
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 35 | $2,528 |
| Abbott Laboratories | 14 | $635 |
| PFIZER INC. | 11 | $233 |
| UCB, Inc. | 13 | $220 |
| Collegium Pharmaceutical, Inc. | 11 | $183 |
| ABBVIE INC. | 11 | $151 |
| Boston Scientific Corporation | 2 | $134 |
| Lundbeck LLC | 4 | $104 |
| Neurelis, Inc. | 4 | $79 |
| Amgen Inc. | 3 | $75 |
Products named: KYPHON EXPRESS II KYPHOPAK TRAY, ETERNA, NURTEC ODT, INTELLIS ADAPTIVESTIM, WaveWriter Alpha Prime 16, Zilbrysq, XTAMPZA, VYEPTI.
Industry payments across MS — which companies pay providers there.
